company logo

US FDA extends certain compliance dates with new trans fat rules

June 11, 2018

The US Food and Drug Administration (FDA) has extended certain compliance deadlines related to its 2015 ban on industrially produced trans fatty acids (IP-TFA) in food while denying a petition to amend the rules.

, US FDA extends certain compliance dates with new trans fat rules

The denied petition, submitted by the Grocery Manufacturers Association (GMA), asked the FDA to amend food additive regulations to include the use of partially hydrogenated oils (PHOs) in certain food applications, reported Food Business News on 18 May.

However, the FDA did extend the compliance date until 18 June 2019 for companies that make products falling under three specific applications:

  • PHO or a blend of PHOs used as a solvent or carrier, or component thereof, for flavouring agents, flavour enhancers and colouring agents intended for food use, provided the PHOs contribute no more than 150ppm of (IP-TFA) to the final product.
  • PHO or a blend of PHOs used as a processing aid, or a component thereof, provided the PHOs contribute no more than 50ppm of IP-TFA to the final product.
  • PHO or a blend of PHOs used as a pan release agent for baked foods at levels up to 0.2g/100g in pan release spray oils, provided the PHO contributes no more than 0.14g of IP-TFA per 100g of spray oil.

“We have denied a trade group’s petition to maintain these uses, and manufacturers will be legally required to remove even these small amounts from food. However in order to provide food makers time to reformulate their products and adjust their manufacturing processes, we’re giving manufacturers extra time to comply for the uses of PHOs requested in the petition,” said Scott Gottlieb, PhD commissioner at the FDA.

All other food products would have to be compliant with the new rules by 18 June 2018.

In 2015, the FDA gave the US food industry three years to eliminate IP-TFAs from the country’s food supply.

Trans fats have been linked to cardiovascular disease and a significantly reduced life expectancy.


Related News